Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

754 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In reply to the Letter to the Editor regarding "Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis".
Gatti M, Cosentino F, Giannella M, Viale P, Pea F. Gatti M, et al. Among authors: viale p. Int J Antimicrob Agents. 2024 Jun;63(6):107168. doi: 10.1016/j.ijantimicag.2024.107168. Epub 2024 Apr 4. Int J Antimicrob Agents. 2024. PMID: 38582401 No abstract available.
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms.
Temkin E, Torre-Cisneros J, Beovic B, Benito N, Giannella M, Gilarranz R, Jeremiah C, Loeches B, Machuca I, Jiménez-Martín MJ, Martínez JA, Mora-Rillo M, Navas E, Osthoff M, Pozo JC, Ramos Ramos JC, Rodriguez M, Sánchez-García M, Viale P, Wolff M, Carmeli Y. Temkin E, et al. Among authors: viale p. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01964-16. doi: 10.1128/AAC.01964-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27895014 Free PMC article.
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
Giannella M, Trecarichi EM, Giacobbe DR, De Rosa FG, Bassetti M, Bartoloni A, Bartoletti M, Losito AR, Del Bono V, Corcione S, Tedeschi S, Raffaelli F, Saffioti C, Spanu T, Rossolini GM, Marchese A, Ambretti S, Cauda R, Viscoli C, Lewis RE, Viale P, Tumbarello M; Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva (ISGRI-SITA). Giannella M, et al. Among authors: viale p. Int J Antimicrob Agents. 2018 Feb;51(2):244-248. doi: 10.1016/j.ijantimicag.2017.08.019. Epub 2017 Aug 24. Int J Antimicrob Agents. 2018. PMID: 28842283 Free article.
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections.
Bartoletti M, Tedeschi S, Pascale R, Raumer L, Maraolo AE, Palmiero G, Tumietto F, Cristini F, Ambretti S, Giannella M, Lewis RE, Viale P. Bartoletti M, et al. Among authors: viale p. Int J Antimicrob Agents. 2018 Mar;51(3):516-521. doi: 10.1016/j.ijantimicag.2018.01.010. Epub 2018 Feb 2. Int J Antimicrob Agents. 2018. PMID: 29410250
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.
Giannella M, Pascale R, Ferraro G, Toschi A, Pancaldi L, Furii F, Bartoletti M, Tedeschi S, Ambretti S, Lewis RE, Viale P. Giannella M, et al. Among authors: viale p. Int J Antimicrob Agents. 2019 May;53(5):574-581. doi: 10.1016/j.ijantimicag.2019.01.005. Epub 2019 Jan 9. Int J Antimicrob Agents. 2019. PMID: 30639527
754 results